Back to Journals » OncoTargets and Therapy » Volume 11

Multiple biological functions of transcription factor 21 in the development of various cancers

Authors Jiang X, Yang Z

Received 29 January 2018

Accepted for publication 26 April 2018

Published 19 June 2018 Volume 2018:11 Pages 3533—3539

DOI https://doi.org/10.2147/OTT.S164033

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Cho


Xiaodi Jiang,1 Zhi Yang2

1Department of Infectious Disease, The Shengjing Hospital of China Medical University, Shenyang, China; 2Department of Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, China

Abstract: Transcription factor 21 (TCF21) is a basic helix–loop–helix transcription factor that binds to DNA and regulates cell differentiation and cell fate specification through mesenchymal–epithelial transition during development. The TCF21 gene is epigenetically inactivated in many types of human cancers and exerts a wide variety of functions, including the regulation of epithelial–mesenchymal transition, invasion, metastasis, cell cycle, and autophagy. This review focuses on research progress in relation to the roles of TCF21 in tumor development. We systematically consider multiple pathological functions of TCF21 in various cancers, revealing the molecular bases of its diverse biological roles and providing new directions for future research.

Keywords:
TCF21, cancer, DNA methylation, EMT, invasion, metastasis, cell cycle

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]